Search

everythinglearnresearchcommunity

for

Search:↓

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

More research is needed to understand if GLP-1 agonists affect hair health.

Acute stress increases Y1 receptor gene expression in certain brain areas, but repeated stress does not.

TAT-GILZ peptide promotes hair growth by boosting stem cell activity.

Skin RAGE levels are linked to inflammation and cell death.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

CRH promotes fat production in skin cells, affecting conditions like acne.

Ubiquitination of the insulin receptor regulates collagen secretion in human skin.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

LPA3 is crucial for embryo implantation and links LPA to prostaglandin signaling.

PPAR-γ helps control skin oil glands and inflammation, and its disruption can cause hair loss diseases.

Metreleptin treatment significantly improved metabolic health in a boy with congenital generalized lipodystrophy.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Mice without active or present vitamin D receptors maintain normal blood sugar control and islet gene expression when calcium levels are normal.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

GLI2 increases follistatin production in human skin cells.

Different types of PPARγ are found in varying amounts in human skin and its parts, which could affect how skin treatments work.

LPAR6 has a unique way of binding and activating, which helps in designing treatments for hair loss and cancer.

Enhanced stem cells from the placenta can reduce fat cell formation in eye disease.

A rash from semaglutide may be due to propylene glycol, not the drug itself.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

A compound named ZCZ90 can increase muscle spindle firing, potentially helping treat muscle spasms and hypertension.